B G Robinson
Overview
Explore the profile of B G Robinson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
1657
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Majumder M, Gild M, Robinson B
Endocrinol Diabetes Metab Case Rep
. 2024 Sep;
2024(3).
PMID: 39342971
Summary: Pregnancy in the setting of metastatic paraganglioma is challenging, particularly in the context of tyrosine kinase use. We describe a 26-year-old female with a background of metastatic paraganglioma harboring...
2.
Gild M, Heath L, Paik J, Clifton-Bligh R, Robinson B
Endocrinol Diabetes Metab Case Rep
. 2020 Feb;
2020.
PMID: 32061155
Summary: Struma ovarii is a rare, usually benign ovarian tumour with malignancy occurring in <5% of cases. Metastases, particularly seeding to bone, are extremely rare. Presentation is variable but often...
3.
Gild M, Bullock M, Pon C, Robinson B, Clifton-Bligh R
Endocr Connect
. 2015 Nov;
5(1):10-9.
PMID: 26574568
Metastatic differentiated thyroid cancers (DTC) are resistant to traditional chemotherapy. Kinase inhibitors have shown promise in patients with progressive DTC, but dose-limiting toxicity is commonplace. HSP90 regulates protein degradation of...
4.
Kim E, Rath E, Tsang V, Duff A, Robinson B, Church W, et al.
Endocr Relat Cancer
. 2015 May;
22(3):387-97.
PMID: 25972245
Mitochondrial dysfunction, due to mutations of the gene encoding succinate dehydrogenase (SDH), has been implicated in the development of adrenal phaeochromocytomas, sympathetic and parasympathetic paragangliomas, renal cell carcinomas, gastrointestinal stromal...
5.
Clifton-Bligh P, Nery M, Supramaniam R, Reeve T, Delbridge L, Stiel J, et al.
Bone
. 2015 Feb;
74:121-4.
PMID: 25637062
561 patients with primary hyperparathyroidism were followed between 1961 and 1994. Relative survival was compared to that of the Australian population studied during the same time interval. Mortality was significantly...
6.
Glover A, Zhao J, Ip J, Lee J, Robinson B, Gill A, et al.
Endocr Relat Cancer
. 2015 Jan;
22(1):99-109.
PMID: 25595289
Adrenocortical carcinoma (ACC) is an aggressive malignancy with high rates of recurrence following surgical resection. Long noncoding RNAs (lncRNAs) play an important role in cancer development. Pathogenesis of adrenal tumours...
7.
Holt D, Henthorn P, Howell V, Robinson B, Benn D
J Comp Pathol
. 2014 May;
151(1):25-34.
PMID: 24813157
Phaeochromocytomas (PCs) are tumours of the adrenal medulla chromaffin cells. Paragangliomas (PGLs) arise in sympathetic ganglia (previously called extra-adrenal PCs) or in non-chromaffin parasympathetic ganglia cells that are usually non-secretory....
8.
Tsang V, Dwight T, Benn D, Meyer-Rochow G, Gill A, Sywak M, et al.
Endocr Relat Cancer
. 2014 Mar;
21(3):415-26.
PMID: 24623741
miR-210 is a key regulator of response to hypoxia. Pheochromocytomas (PCs) and paragangliomas (PGLs) with germline SDHx or VHL mutations have pseudohypoxic gene expression signatures. We hypothesised that PC/PGLs containing...
9.
Bullock M, ONeill C, Chou A, Clarkson A, Dodds T, Toon C, et al.
Endocr Relat Cancer
. 2012 Sep;
19(6):779-84.
PMID: 22997209
Identification of BRAF(V600E) in thyroid neoplasia may be useful because it is specific for malignancy, connotes a worse prognosis, and is the target of novel therapies currently under investigation. Sanger...
10.
Soon P, Gill A, Benn D, Clarkson A, Robinson B, McDonald K, et al.
Endocr Relat Cancer
. 2009 Feb;
16(2):573-83.
PMID: 19218281
The management of adrenocortical tumors (ACTs) is complex. The Weiss score is the present most widely used system for ACT diagnosis. An ACT is scored from 0 to 9, with...